Kizzmekia Corbett

American immunologist

Why Is Kizzmekia Corbett Influential?

According to Wikipedia, Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.

Kizzmekia Corbett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation (2020) (5466)
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) (1674)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) (682)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen (2017) (641)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) (577)
Pre-fusion structure of a human coronavirus spike protein (2016) (527)
SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness (2020) (511)
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (346)
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation (2020) (327)
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (2021) (326)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (277)
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (2021) (203)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies (2020) (185)
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (2021) (143)
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape (2018) (129)
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (118)
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (118)
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection (2020) (111)
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness (2020) (109)
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses (2020) (78)
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (74)
Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus (2011) (73)
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance (2020) (73)
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates (2021) (67)
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD (2019) (60)
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants (2021) (59)
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses (2021) (55)
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report. (2021) (54)
Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort. (2015) (51)
Erratum: Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (Cell (2020) 181(5) (1004–1015.e15), (S0092867420304943), (10.1016/j.cell.2020.04.031)) (2020) (49)
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice (2021) (49)
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages (2019) (46)
Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies (2018) (40)
Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles (2015) (38)
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates (2021) (35)
A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone (2020) (29)
Mucosal Delivery of Human Papillomavirus Pseudovirus-Encapsidated Plasmids Improves Potency of DNA Vaccination (2010) (29)
Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka. (2014) (27)
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (26)
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (2021) (24)
Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. (2018) (21)
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants (2021) (21)
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates (2021) (20)
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses (2020) (19)
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone (2020) (18)
mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates (2021) (17)
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (2021) (16)
Prototype pathogen approach for pandemic preparedness: world on fire. (2020) (14)
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit (2021) (14)
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (13)
Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates (2021) (13)
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses (2021) (11)
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2021) (11)
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates (2021) (10)
A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry (2019) (10)
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung (2022) (10)
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron (2022) (10)
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques (2021) (8)
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates (2021) (8)
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge (2021) (8)
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques (2021) (6)
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up (2020) (6)
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice (2021) (4)
The duty to mentor, be visible and represent. (2020) (4)
Stabilized coronavirus spike stem elicits a broadly protective antibody (2021) (4)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (4)
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. (2020) (3)
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway (2021) (3)
Prefusion coronavirus spike proteins and their use (2017) (3)
From mRNA sensing to vaccines (2021) (2)
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020 (2020) (2)
Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike (2018) (1)
Design of nanoparticulate group 2 influenza hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages (2018) (1)
Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike (2018) (1)
Career advice from my father: “Go where you are loved” (2021) (0)
Voices of biotech research. (2021) (0)
Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses (2022) (0)
Title: Immune Correlates of Protection by mRNA-1273 Immunization against 1 SARS-CoV-2 Infection in Nonhuman Primates (2021) (0)
Characterization of Human Antibody Responses to Dengue Virus Infections in a Sri Lankan Pediatric Cohort (2014) (0)
Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43 (2021) (0)
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability (2022) (0)

This paper list is powered by the following services:

Other Resources About Kizzmekia Corbett

en.wikipedia.org

What Schools Are Affiliated With Kizzmekia Corbett?

Kizzmekia Corbett is affiliated with the following schools:

University of Maryland, Baltimore County
University of North Carolina at Chapel Hill
Stony Brook University